Comparison of the efficacy of nebulised budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease

Clinical Drug Investigation

Volumn 23, Issue 1, 2003, Pages 55-62

  Mirici, A ^a   Meral, M ^a   Akgun, M ^a,b  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; NEBUAMPUL; RESPULE; SALBUTAMOL;

ADULT; ADVERSE DRUG REACTION; AIRWAY OBSTRUCTION; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; GAS EXCHANGE; HOSPITALIZATION; HUMAN; OXYGEN SATURATION; PEAK EXPIRATORY FLOW; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0037251095     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200323010-00007     Document Type: Article

References (22)

1. Turkish Thoracic Society -COPD Study Group. The national guidelines to diagnosis and treatment of chronic obstructive pulmonary disease [in Turkish]. Toraks Dergisi 2000; 1 Suppl. 2: 1-25
2. National Heart, Lung, and Blood Institute. Global initiative for chronic obstructive lung disease. NHLBI Workshop Report 2701; 2001 Apr, Chapter 4
3. ATS Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 78-83
4. Jeffery PK. Pathology of asthma and COPD. Eur Respir Rev 1997; 7 (43): 111-8
5. Fabbri LM, Durham S, Holgate ST, et al. Assessment of airway inflammation: an overview. Eur Respir J Suppl 1998 Mar; 26: 6S-8S
6. National Heart, Lung, and Blood Institute. Global Initiative for Asthma. NHLBI/WHO Workshop Report 2002. NIH Publication No: 02-3659. Available from URL: http//www.ginasthma.com/ [Accessed 2002 Jun 10]
7. Turkish Thoracic Society - Asthma Study Group. The national guideline of diagnosis and treatment of asthma [in Turkish]. Toraks Dergisi 2000; 1 Suppl. 1: 1-32
8. Mirici A, Bektas Y, Ozbakis G, et al. Effect of inhaled corticosteroids on respiratory function tests and airway inflammation in stable chronic obstructive pulmonary disease. Clin Drug Invest 2001; 21 (12): 835-42
9. Posthma DS, Kerstjens HAM. Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 1999; 160: 66-71
10. Niewoehner D, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999; 340: 1941-7
11. Sayiner A, Aytemur ZA, Cirit M, et al. Systemic glucocorticosteroids in severe exacerbations of COPD. Chest 2001; 119: 726-30
12. Westbroek J, Saarelainen S, Laher M, et al. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma. Respir Med 1999; 93: 689-99
13. Winter JH, Dhillon BP, Winter JE, et al. Effect of the early substitution of nebulized fluticasone proprionate 2mg bid for oral prednisolone 50mg in adults during the early recovery period of an acute exacerbation. Eur Respir J 1997; 25 (Suppl): 174s
14. Saetta M. Airway pathology of COPD compared with asthma. Eur Respir Rev 1997; 7 (45): 211-5
15. Calverley PMA, Rennard S, Agusti AGN, et al. Current and future management of acute exacerbations of chronic obstructive pulmonary disease. Eur Respir Rev 1999; 9 (67): 193-205
16. Morice AH, Morris D, Lawson-Matthew P. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin Pharmacol Ther 1996 Dec; 60 (6): 675-8
17. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2002 Mar 1; 165 (5): 698-703
18. Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory failure. Ann Intern Med 1980; 92: 753-8
19. Thompson WH, Nielson CP, Carvalbo P, et al. Controlled trial of oral prednisolone in outpatients with COPD exacerbation. Am J Respir Crit Care Med 19961 154: 407-12
20. Murata GH, Gorby MS, Chick TW. Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD: effects on patients with a history of multiple relapses. Chest 2000; 98: 845-9
21. Rubini F, Rampulla C, Nava S. Acute effect of corticosteroids on respiratory mechanics in mechanically ventilated patients with chronic airflow obstruction and acute respiratory failure. Am J Respir Crit Care Med 1994; 149: 306-10
22. Decramer M, Stas K. Corticosteroid-induced myopathy involving respiratory muscles in patients with COPD and asthma. Am Rev Respir Dis 1992; 146: 800-2